Sign in
4

Changes in Ownership

KALA BIO, Inc. Filed Acc 0001415889-23-004973

Options or other derivatives

  • CHIEF EXECUTIVE OFFICER acquired 1,512 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Iwicki Mark T CHIEF EXECUTIVE OFFICER 2023-03-14 Grant or award · Stock Option (Right to Buy) +1,512 1,512 D
Loading xslF345X03/form4-03152023_080301.xml…